From: DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer
Variables | Total | DSG2 expression | Pa | |
---|---|---|---|---|
Low | High | |||
Age (years) | ||||
≤ 42 | 65 | 42 | 23 | 0.313 |
> 42 | 85 | 48 | 37 | |
FIGO stageb | ||||
I | 132 | 87 | 45 | 0.187 |
II | 18 | 9 | 9 | |
Tumor size (cm) | ||||
≤ 4 | 125 | 85 | 40 | 0.022 |
> 4 | 25 | 11 | 14 | |
Pathologic types | ||||
Squamous cell carcinoma | 128 | 82 | 46 | 0.205a |
Adenocarcinoma | 18 | 13 | 5 | |
Adenosquamous carcinoma | 4 | 1 | 3 | |
Differentiation grade | ||||
Well | 5 | 4 | 1 | 0.502a |
Moderate | 69 | 45 | 24 | |
Poor | 69 | 43 | 26 | |
Stromal invasion | ||||
< 1/2 | 87 | 58 | 29 | 0.424 |
≥ 1/2 | 63 | 38 | 25 | |
Lymphovascular space invasion | ||||
No | 134 | 89 | 45 | 0.074 |
Yes | 16 | 7 | 9 | |
Pelvic lymph node metastasis | ||||
No | 120 | 89 | 31 | < 0.001 |
Yes | 30 | 7 | 23 | |
Vaginal involvement | ||||
No | 148 | 94 | 54 | 0.408 |
Yes | 2 | 2 | 0 | |
Parametrial infiltration | ||||
No | 149 | 95 | 54 | 0.64 |
Yes | 1 | 1 | 0 | |
Recurrence | ||||
No | 126 | 89 | 37 | < 0.001 |
Yes | 24 | 7 | 17 | |
Vital status in 5 years | ||||
Alive | 129 | 92 | 37 | < 0.001 |
Dead | 21 | 4 | 17 |